CLASS III Device recall · Reported 12 Feb 2020 · FDA Enforcement Report

Liquid Clinical Chemistry Control recalled by Randox Laboratories

Randox Laboratories is recalling Liquid Clinical Chemistry Control, distributed in New York. The recall was initiated on 13 Dec 2019 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesCatalogue Number: LAE4217 GTIN: 05055273208993 Lot Number: 1021UE (EXP: 2020-06-28)
Quantity recalled2

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1100-2020
FDA event ID
84547
Recalling firm
Randox Laboratories, Crumlin (North), N/A
Classification
Class III
Status
Terminated
Recall initiated
13 Dec 2019
FDA classified
6 Feb 2020
Reported
12 Feb 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

13 Dec 2019Recall initiated by company
6 Feb 2020Classified by FDA+55 days
12 Feb 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A transcription error has occurred for the Randox Lipase colorimetric value in Liquid Clinical Chemistry Control lot 1021 UE. The target and range are listed as 50 U/L (40 - 60) and should be 72U/L (58 - 86).

Product as listed by the FDA

Liquid Clinical Chemistry Control, Catalogue Number: LAE4217, Size: 12 x 5 ml

Where it was distributed

US: NY and DE OUS: France, Lithuania, Poland, Spain, Switzerland, Turkey, Australia, Hong Kong, Bosnia and Herzegovina, Costa Rica, Ecuador, Gambia, New Zealand and Solomon Islands.

New York

Stores named: Target

Questions about this recall

Is Liquid Clinical Chemistry Control recalled?

Yes. Randox Laboratories recalled Liquid Clinical Chemistry Control on 13 Dec 2019. The recall is Class III and its status is Terminated. Recall number Z-1100-2020.

Why was it recalled?

A transcription error has occurred for the Randox Lipase colorimetric value in Liquid Clinical Chemistry Control lot 1021 UE. The target and range are listed as 50 U/L (40 - 60) and should be 72U/L (58 - 86).

Which lots are affected?

Catalogue Number: LAE4217 GTIN: 05055273208993 Lot Number: 1021UE (EXP: 2020-06-28)

Where was it sold?

US: NY and DE OUS: France, Lithuania, Poland, Spain, Switzerland, Turkey, Australia, Hong Kong, Bosnia and Herzegovina, Costa Rica, Ecuador, Gambia, New Zealand and Solomon Islands.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Randox Laboratories

All 98

Other Other Medical Devices recalls

All 13,778